Georgian Pharmaceutical Association blamed the Ministry of Health for the deficit of drugs on the market
The Pharmaceutical Association of Georgia accused the Ministry of Health of an ill-conceived attempt to regulate the market, which led to a shortage of medicines.
“Instead of cooperation from the Ministry of Health, we hear unfounded accusations that are probably put forward in order to cover up poorly thought–out reforms that led to a shortage in the market after the introduction of reference prices,” the statement says.
At this stage, the reference price is set by the Ministry of Health for 1,620 names of medicines – but as a result, only 600 of them are available in Georgia.
The statement of the Association states, in particular, that the policy of the Ministry of Health has led to problems with the import of a whole list of antiepileptic drugs to Georgia, including finlepsin.
“The public should know that as a result of the mistakenly carried out reform, there is already a shortage of European drugs of high reliability and quality on the market”, the statement says. As for medicines from Turkey, which should be imported at low prices, the Turkish side cannot ensure full supply.
Already, all this has led to the fact that the black market of medicines is gaining momentum in Georgia, where neither quality nor price are regulated, the association notes.
The full text of the statement was distributed by the BM portal.ge, here are also lists of drugs with the supply of which there have been, or may be problems.
Reference prices – the upper limit of prices, were introduced by the Ministry of Health of Georgia in March of this year for 1100 drugs, then their number increased to 1600.
In July, the Ministry of Health accused pharmaceutical companies of creating an artificial shortage, including for Depakine Chrono, which is used to treat various types of epilepsy in children and adults.
newsgeorgia.ge
Tags:
Georgian Pharmaceutical Association blamed the Ministry of Health for the deficit of drugs on the market
The Pharmaceutical Association of Georgia accused the Ministry of Health of an ill-conceived attempt to regulate the market, which led to a shortage of medicines.
“Instead of cooperation from the Ministry of Health, we hear unfounded accusations that are probably put forward in order to cover up poorly thought–out reforms that led to a shortage in the market after the introduction of reference prices,” the statement says.
At this stage, the reference price is set by the Ministry of Health for 1,620 names of medicines – but as a result, only 600 of them are available in Georgia.
The statement of the Association states, in particular, that the policy of the Ministry of Health has led to problems with the import of a whole list of antiepileptic drugs to Georgia, including finlepsin.
“The public should know that as a result of the mistakenly carried out reform, there is already a shortage of European drugs of high reliability and quality on the market”, the statement says. As for medicines from Turkey, which should be imported at low prices, the Turkish side cannot ensure full supply.
Already, all this has led to the fact that the black market of medicines is gaining momentum in Georgia, where neither quality nor price are regulated, the association notes.
The full text of the statement was distributed by the BM portal.ge, here are also lists of drugs with the supply of which there have been, or may be problems.
Reference prices – the upper limit of prices, were introduced by the Ministry of Health of Georgia in March of this year for 1100 drugs, then their number increased to 1600.
In July, the Ministry of Health accused pharmaceutical companies of creating an artificial shortage, including for Depakine Chrono, which is used to treat various types of epilepsy in children and adults.
newsgeorgia.ge
Tags:
